MYC and lymphoma: Swiderska et al. used AI to predict MYC rearrangements based on H&E morphology, reducing the need for FISH testing, while Tavolara et al. quantified c-MYC and BCL2 expression with AI, enabling prognostic stratification in double-expressor lymphomas [19,24].